This is a pioneering effort that will change the game in behavioral healthcare. This is the first behavioral intervention for a a psychiatric disorder using operant conditioning principles driven by physiological measurement and feedback.
Quietmind Foundation has been using the Freespira program with very positive results with our patients who wish to learn to modify their anxiety and panic symptoms without medication or psychotherapy.
We are offering people with panic or anxiety symptoms the opportunity to try the Freespira system for a reduced fee in exchange for allowing recording of their brainwave activity before and after the one month trial period. Quietmind will continue to collaborate with Palo Alto Health Systems as the only clinic offering Freespira training in the Delaware Valley.
Call 610-940-0488 for details.
Click here for the full article:
We can now see further evidence that near infrared light stimulation can positively influence beta amyloid production and this can have a significant impact on people with cognitive decline from neurodegenerative Alzheimer's and Parkinson's disease.
Quietmind Fdn. is using these technologies in our current clinical trials. Call 610-940-0488 for details.
The model for treatment developed over my career as a body-centered psychotherapist included training in The Feldenkrais Method with Moshe Feldenkrais and it has remained a stabilizing pillar of how I conceptualize both my clinical and research activity in the neuromodulation field.
The article that appeared in the NYT this week focuses on the use of Feldenkrais techniques to reduce chronic pain symptoms and provide a very useful alternative way of thinking and responding to pain. The inclusion of neuromodulation techniques has given me an additional method for helping to release and re-educate our nervous system from the inside out.
Quietmind will be collaborating with Joann Fagersrom, PT, CFP who owns Mindful Physical Therapy, LLC to integrate the use of neurofeedback with Awareness Through Movement exercises in the treatment of chronic pain and other neurodegenerative conditions.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.